Hoping to forestall a congressional probe, the St. Regis Mohawk Tribe sent an angry letter to the U.S. Senate Judiciary Committee complaining that criticism of its controversial deal to obtain valuable patents from Allergan (AGN) is misguided, inaccurate, and unfair. Several lawmakers have denounced the deal as a cynical maneuver designed to thwart competition from lower-cost generic medicines.
In arguing against an inquiry, the tribal leaders wrote the committee that the federal government “should not force Indian Country to bear the consequences of partisan disagreements about how to control drug prices and deliver affordable healthcare.” And they insisted the government should fix pollution problems harming the tribe, rather than scrutinize a deal that provides needed revenue.
About the Author Reprints
